Cargando...
Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases
INTRODUCTION: Trastuzumab therapy significantly improves progression-free and overall survival in HER2-positive [HER2(+)] breast cancer (BC) patients. However, in most patients with HER2(+) metastatic BC, the disease progress occurred. The aim of this study was to evaluate the clinicopathological ri...
Gardado en:
| Publicado en: | Prz Menopauzalny |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Termedia Publishing House
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4612553/ https://ncbi.nlm.nih.gov/pubmed/26528105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pm.2015.54341 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|